Skip to main content
SpringerLink
Log in

Blutzuckerselbstkontrolle (Update 2019)

Blood glucose self monitoring (Update 2019)

  • leitlinien für die praxis
  • Published:
Wiener klinische Wochenschrift Aims and scope Submit manuscript

Zusammenfassung

Blutzuckerselbstkontrolle trägt zum integrierten Management des Diabetes mellitus bei. Sie sollte für alle Patienten mit Diabetes mellitus zur Verfügung stehen. Die Blutzuckerselbstkontrolle erhöht die Patientensicherheit, die Lebensqualität und verbessert die Blutzuckerkontrolle. Der vorliegende Artikel stellt die Behandlungsvorschläge der Österreichischen Diabetes Gesellschaft zum Einsatz der Blutzuckerselbstkontrolle dar.

Summary

Self monitoring of blood glucose contributes to the integrated management of diabetes mellitus. It, thus, should be available for all patients with diabetes mellitus. Self monitoring of blood glucose improves patients safety, quality of life and glucose control. The current article represents the recommendations of the Austrian Diabetes Association for the use of blood glucose self monitoring according to current scientific evidence.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Pfuetzner A, Weissmann J, Mougiakakou S, Daskalaki E, Weis N, Ziegler R. Glycemic variability is associated with frequency of blood glucose testing and bolus: post hoc analysis results from the proact study. Diabetes Technol Ther. 2015; https://doi.org/10.1089/dia.2014.0278.

    Article  Google Scholar 

  2. Miller KM, Beck RW, Bergenstal RM, Goland RS, Haller MJ, McGill JB, Rodriguez H, Simmons JH, Hirsch IB. T1D Exchange Clinic Network: evidence of a strong association between frequency of self-monitoring of blood glucose and hemoglobin A1c levels in T1D Exchange Clinic Registry participants. Diabetes Care. 2013;36:2009–14.

    Article  Google Scholar 

  3. Houle J, Beaulieu MD, Chiasson JL, Lesperance F, Cote J, Strychar I, Bherer L, Meunier S, Lambert J. Glycaemic control and self-management behaviours in type 2 diabetes: results from a 1-year longitudinal cohort study. Diabet Med. 2015; https://doi.org/10.1111/dme.12686.

    Article  PubMed  Google Scholar 

  4. Schütt M, Kern W, Krause U, Busch P, Dapp A, Grziwotz R, Mayer I, Rosenbauer J, Wagner C, Zimmermann A, Kerner W, Holl RW, DPV Initiative. Is the frequency of self-monitoring of blood glucose related to long-term metabolic control? Multicenter analysis including 24,500 patients from 191 centers in Germany and Austria. Exp Clin Endocrinol Diabetes. 2006;114(7):384–8.

    Article  Google Scholar 

  5. Welschen LM, Bloemendal E, Nijpels G, Dekker JM, Heine RJ, Stalman WA, Bouter LM. Self-monitoring of blood glucose in patients with type 2 diabetes mellitus who are not using insulin. Cochrane Database Syst Rev. 2005; https://doi.org/10.1002/14651858.cd005060.pub2.

    Article  PubMed  Google Scholar 

  6. Jansen JP. Self-monitoring of glucose in type 2 diabetes mellitus: a Bayesian meta-analysis of direct and indirect comparisons. Curr Med Res Opin. 2006;22(4):671–81.

    Article  CAS  Google Scholar 

  7. Schwedes U, Siebolds M, Mertes G, SMBG Study Group. Meal-related structured self-monitoring of blood glucose: effect on diabetes control in non-insulin-treated type 2 diabetic patients. Diabetes Care. 2002;25(11):1928–32.

    Article  Google Scholar 

  8. Farmer A, Wade A, Goyder E, Yudkin P, French D, Craven A, Holman R, Kinmonth AL, Neil A. Impact of self monitoring of blood glucose in the management of patients with non-insulin treated diabetes: open parallel group randomised trial. BMJ. 2007;335(7611):132.

    Article  Google Scholar 

  9. Martin S, Schneider B, Heinemann L, Lodwig V, Kurth HJ, Kolb H, Scherbaum WA. Self-monitoring of blood glucose in type 2 diabetes and long-term outcome: an epidemiological cohort study. Diabetologia. 2006;49(2):271–8.

    Article  CAS  Google Scholar 

  10. Barnett AH, Krentz AJ, Strojek K, Sieradzki J, Azizi F, Embong M, Imamoglu S, Perusicová J, Uliciansky V, Winkler G. The efficacy of self-monitoring of blood glucose in the management of patients with type 2 diabetes treated with a gliclazide modified release-based regimen. A multicentre, randomized, parallel-group, 6‑month evaluation (DINAMIC 1 study). Diabetes Obes Metab. 2008;10(12):1239–47.

    CAS  PubMed  Google Scholar 

  11. Malanda UL, Welschen LMC, Riphagen II, Dekker JM, Nijpels G, Bot SDM. Self-monitoring of blood glucose in patients with type 2 diabetes mellitus who are not using insulin. Cochrane Database Syst Rev. 2012; https://doi.org/10.1002/14651858.cd005060.pub3.

    Article  PubMed  Google Scholar 

  12. Farmer AJ, Perera R, Ward A, Heneghan C, Oke J, Barnett AH, Davidson MB, Guerci B, Coates V, Schwedes U, O’Malley S. Meta-analysis of individual patient data in randomised trials of self monitoring of blood glucose in people with non-insulin treated type 2 diabetes. BMJ. 2012;344:e486. https://doi.org/10.1136/bmj.e486.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. 1. Medizinische Abteilung, Hanuschkrankenhaus, Heinrich-Collin-Straße 30, 1140, Wien, Österreich

    Thomas C. Wascher

  2. Universitätsklinik für Innere Medizin I, Paracelsus Medizinische Privatuniversität – Landeskrankenhaus, Salzburg, Österreich

    Lars Stechemesser

  3. Klinische Abteilung für Endokrinologie und Stoffwechsel, Universitätsklinik für Innere Medizin III, Medizinische Universität Wien, Wien, Österreich

    Jürgen Harreiter

Authors
  1. Thomas C. Wascher
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Lars Stechemesser
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jürgen Harreiter
    View author publications

    You can also search for this author in PubMed Google Scholar

Consortia

den Ausschuss Leitlinien

Corresponding author

Correspondence to Thomas C. Wascher.

Ethics declarations

Interessenkonflikt

T.C. Wascher hat von folgenden Unternehmen, die auch fördernde Mitglieder der ÖDG sind, Forschungsunterstützungen und/oder Honorare erhalten: Abbott, Roche. L. Stechemesser hat von folgenden Unternehmen, die auch fördernde Mitglieder der ÖDG sind, Forschungsunterstützungen und/oder Honorare erhalten: Abbott, Roche. J. Harreiter hat von folgenden Unternehmen, die auch fördernde Mitglieder der ÖDG sind, Forschungsunterstützungen und/oder Honorare erhalten: Astra Zeneca, Novo Nordisk, Takeda.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wascher, T.C., Stechemesser, L., Harreiter, J. et al. Blutzuckerselbstkontrolle (Update 2019). Wien Klin Wochenschr 131 (Suppl 1), 115–118 (2019). https://doi.org/10.1007/s00508-018-1436-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00508-018-1436-7

Schlüsselwörter

Keywords

Search

Navigation